| ASQIX | FSSNX | ASQIX / FSSNX | |
| Total Expense Ratio | 0.85 | 0.03 | 3,400% |
| Annual Report Gross Expense Ratio | 0.85 | 0.03 | 3,400% |
| Fund Existence | 27 years | 14 years | - |
| Gain YTD | 12.966 | 14.342 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 161M | 29.3B | 1% |
| Annual Yield % from dividends | 0.28 | 0.80 | 36% |
| Returns for 1 year | 11.52 | 12.91 | 89% |
| Returns for 3 years | 42.77 | 49.70 | 86% |
| Returns for 5 years | 13.12 | 31.28 | 42% |
| Returns for 10 years | 47.98 | 119.63 | 40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RLCAX | 8.70 | 0.03 | +0.35% |
| Columbia Disciplined Value A | |||
| AEIMX | 8.55 | 0.03 | +0.35% |
| American Century Equity Income G | |||
| DWOCX | 14.65 | 0.03 | +0.21% |
| BNY Mellon Research Growth C | |||
| HRCPX | 68.20 | 0.14 | +0.21% |
| Carillon ClariVest Capital Apprec A | |||
| GEMLX | 15.00 | 0.03 | +0.20% |
| Goldman Sachs Emerging Mkts Eq ex. Chn C | |||